iNtRON Biotechnology
VC Fund
Seongnam, South Korea
iNtRON Biotechnology is a VC fund in Seongnam focused on Health Care and Biotechnology. iNtRON Biotechnology develops and manufactures molecular diagnostic assays based on real-time PCR and multiplex PCR kits.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries iNtRON Biotechnology invests in
Stages iNtRON Biotechnology invests in
Countries iNtRON Biotechnology invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kyung-won Yoon
|
|||
|
Sung-Soo Jang
|
|||
Investment Focus
Industry
- Health Care 1 (50%)
- Biotechnology 1 (50%)
Stage
- Series B 1 (50%)
- Venture - Series Unknown 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Kyung-won Yoon
CEO/ Vice President
|
CEO/ Vice President | Total investments: 1 | Find email | |
|
Sung-Soo Jang
CEO and President
|
CEO and President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
LISCure Biosciences is a developer of bacteria-mediated immunotherapy designed to treat tumors as well as degenerative neurological, autoimmune and metabolic diseases. The company currently has seven pipelines of medicine and two pipelines of health-functioning food and is considering the introduction of two more pipes. | $13.6M / Venture - Series Unknown / Jan 10, 2025 | |
|
|
LISCure Biosciences is a developer of bacteria-mediated immunotherapy designed to treat tumors as well as degenerative neurological, autoimmune and metabolic diseases. The company currently has seven pipelines of medicine and two pipelines of health-functioning food and is considering the introduction of two more pipes. | $9.3M / Series B / Dec 31, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does iNtRON Biotechnology invest in?
iNtRON Biotechnology invests primarily in Health Care and Biotechnology startups, most often at Series B and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact iNtRON Biotechnology?
Public channels for iNtRON Biotechnology include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at iNtRON Biotechnology?
The team at iNtRON Biotechnology includes Kyung-won Yoon (CEO/ Vice President) and Sung-Soo Jang (CEO and President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!